or Try an Advanced Search...

    Tyrosine Kinase Stocks List

    Symbol Grade Name % Change
    RIGL B Rigel Pharmaceuticals, Inc. 2.71
    EXEL B Exelixis, Inc. 0.35
    BPMC C Blueprint Medicines Corporation 2.30
    NRIX C Nurix Therapeutics, Inc. 0.09
    AVBP C ArriVent BioPharma, Inc. -2.39
    KALA C Kala Pharmaceuticals, Inc. 1.71
    PBYI C Puma Biotechnology Inc 2.46
    COGT D Cogent Biosciences, Inc. -0.11
    NVCT D Nuvectis Pharma, Inc. -2.76
    EYPT D EyePoint Pharmaceuticals, Inc. -6.09
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Enzymes Fibroblast Growth Factor Receptor Protein Kinase Inhibitor Solid Tumors Tyrosine Kinase Receptors Achondroplasia Acute Myeloid Leukemia Advanced Solid Tumors Amyloid Amyloidosis Biology Biopharmaceutical Cancer Cancer Therapeutics Cardiomyopathy Clinical Development Congenital Adrenal Hyperplasia Cyclin Dependent Kinase Doxorubicin Drug Discovery

    Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase stocks.

    Symbol Grade Name Weight
    IDNA D iShares Genomics Immunology and Healthcare ETF 9.59
    CANC D Tema Oncology ETF 9.08
    PBE D PowerShares Dynamic Biotech & Genome 6.77
    CNCR F Loncar Cancer Immunotherapy ETF 4.77
    FBT D First Trust Amex Biotech Index Fund 4.51
    View all Tyrosine Kinase ETFs...
    Compare ETFs
    Compare CANC to FBT Compare IDNA to FBT Compare IDNA to PBE

        Tyrosine Kinase Stocks Recent News

        Date Stock Title
        Nov 21 PBYI PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer
        Nov 21 PBYI Puma commences Phase II trial of alisertib for breast cancer treatment
        Nov 20 NRIX Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
        Nov 20 PBYI Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
        Nov 20 EXEL Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity
        Nov 19 RIGL How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
        Nov 19 RIGL Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive
        Nov 18 RIGL 5 Relative Price Strength Options Available for Investors
        Nov 17 NRIX Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
        Nov 15 BPMC Blueprint Medicines' Growth With AYVAKIT And Next-Gen Oncology Drugs
        Nov 15 RIGL Exploring Three High Growth Tech Stocks in the United States
        Nov 15 NVCT Nuvectis Pharma reports data from Phase 1b study of NXP800
        Nov 15 AVBP ArriVent BioPharma GAAP EPS of -$0.61 beats by $0.11
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biopharmaceutical Protein Kinase Inhibitor Biotechnology Enzymes Ophthalmic Receptor Tyrosine Kinase Treatment Of Cancer Chemical Compounds Daiichi Sankyo Eye Gastrointestinal Gastrointestinal Stromal Tumor Glucocorticoids Inflammation Life Sciences Macular Degeneration Mastocytosis Medicine Non Small Cell Lung Cancer
        Tyrosine Kinase

        Tyrosine kinase is an enzyme that catalyzes the transfer of phosphate groups from ATP to tyrosine residues on proteins. It is involved in many cellular processes, including cell growth, differentiation, and migration. Tyrosine kinases are also involved in signal transduction pathways, which are important for cell communication and regulation. Mutations in tyrosine kinases can lead to cancer and other diseases.

        Browse All Tags